Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 393)
Posted On: 08/08/2021 11:06:40 AM
Post# of 36564
Posted By: Buildit
Re: docj #31264
We have known for a while that there are breakthrough cases. And, as a higher percentage of a population is vaccinated, it makes sense that more cases would start so be in the vaccinated population. Israel has fully vaccinated 64+% of their population.

But the key is the severity of the illness on breakthrough cases. Are there fewer hospitalizations and deaths?

It is interesting that Dr Malone chooses to pull out the “severe” cases to make his point and not include “critical” cases or deaths. Did the critical patients and number of deaths not meet his standard of scare?

A quick Google of Dr Malone finds plenty of other Drs and researchers are skeptical of Dr Malone and his interpretation/reporting of data on vaccines.

So while there certainly may be a waning of efficacy of the vaccines, it seems we should wait until the full, peer-reviewed data is available before we make judgement.

I suppose that’s the same for our “Complete Vaccine”. Where is our peer review paper?














(1)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site